ATE254660T1 - Methode zur markierung von eukaryotischen zellen mittels verwendung von rezeptoren der zelloberfläche als marker - Google Patents

Methode zur markierung von eukaryotischen zellen mittels verwendung von rezeptoren der zelloberfläche als marker

Info

Publication number
ATE254660T1
ATE254660T1 AT94926187T AT94926187T ATE254660T1 AT E254660 T1 ATE254660 T1 AT E254660T1 AT 94926187 T AT94926187 T AT 94926187T AT 94926187 T AT94926187 T AT 94926187T AT E254660 T1 ATE254660 T1 AT E254660T1
Authority
AT
Austria
Prior art keywords
pct
receptor
cell surface
nucleic acid
cell
Prior art date
Application number
AT94926187T
Other languages
English (en)
Inventor
Claudio Bordignon
Fulvio Mavilio
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11401929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE254660(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of ATE254660T1 publication Critical patent/ATE254660T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT94926187T 1993-09-01 1994-08-11 Methode zur markierung von eukaryotischen zellen mittels verwendung von rezeptoren der zelloberfläche als marker ATE254660T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM930587A IT1261847B (it) 1993-09-01 1993-09-01 Metodo per marcare cellule eucariote.
PCT/EP1994/002687 WO1995006723A1 (en) 1993-09-01 1994-08-11 Method of marking eukaryotic cells by the use of a cell surface receptor as a marker

Publications (1)

Publication Number Publication Date
ATE254660T1 true ATE254660T1 (de) 2003-12-15

Family

ID=11401929

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94926187T ATE254660T1 (de) 1993-09-01 1994-08-11 Methode zur markierung von eukaryotischen zellen mittels verwendung von rezeptoren der zelloberfläche als marker

Country Status (12)

Country Link
US (1) US6074836A (de)
EP (1) EP0724634B1 (de)
JP (1) JP2781276B2 (de)
AT (1) ATE254660T1 (de)
CA (1) CA2170757C (de)
DE (1) DE69433342T2 (de)
DK (1) DK0724634T3 (de)
ES (1) ES2210260T3 (de)
IL (2) IL110815A0 (de)
IT (1) IT1261847B (de)
PT (1) PT724634E (de)
WO (1) WO1995006723A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19643682C1 (de) * 1996-10-23 1998-01-15 Manfred Prof Dr Gareis Verfahren zum Herkunftsnachweis von Nutztieren sowie davon stammenden Produkten
US6500421B1 (en) * 1996-11-04 2002-12-31 St. Jude Children's Research Hospital In vivo selection of primitive hematopoietic cells
EP0972829A4 (de) * 1997-01-31 2001-01-03 Dnavec Research Inc Tiere mit geninaktivierung
ES2232845T3 (es) * 1997-08-22 2005-06-01 Science Park Raf S.P.A. Vacunacion tumoral mediante la utilizacion de celulas autologas o celulas presentadoras de antigeno (apc) relacionadas con hla transducidas con un antigeno tumoral y un antigeno ajeno capaz de producir una reaccion inmune.
ZA989497B (en) * 1997-10-20 2000-04-19 Roche Diagnostics Gmbh Positive-negative selection in homologous recombination.
IT1297016B1 (it) * 1997-12-23 1999-08-03 San Raffaele Centro Fond Processo di selezione di linfociti t cd4+ per la transduzione di geni anti-hiv
IT1312570B1 (it) * 1999-05-28 2002-04-22 Genera Spa Metodo per il traferimento di antigeni a cellule dendritiche.
EP1278773A2 (de) * 1999-11-19 2003-01-29 Novartis AG Selektierbare zelloberflächenmarkergenen
US6790614B1 (en) 1999-11-19 2004-09-14 Novartis Ag Selectable cell surface marker genes
JP2003533183A (ja) * 2000-03-30 2003-11-11 ノバルティス アクチエンゲゼルシャフト 選択マーカー遺伝子
DE10019075B4 (de) * 2000-04-18 2007-01-18 Vision 7 Gmbh Verwendung von CD34 oder einem davon abgeleiteten Polypeptid als Zell-Oberflächen- bzw. Gentransfer-Marker
WO2002097059A2 (en) * 2001-05-30 2002-12-05 Chromos Molecular Systems, Inc. Chromosome-based platforms
US7737124B2 (en) 2001-09-13 2010-06-15 California Institute Of Technology Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
US7919309B2 (en) 2001-09-13 2011-04-05 California Institute Of Technology Method for expression of small antiviral RNA molecules within a cell
CN1780920B (zh) * 2003-05-12 2012-03-28 波多玛克制药有限公司 基因表达抑制剂
GB0413702D0 (en) 2004-06-18 2004-07-21 Molmed Spa Thymidine kinase
US8828727B2 (en) 2004-07-21 2014-09-09 Dana-Farber Cancer Institute Lentiviral vectors and uses thereof
WO2013050523A1 (en) 2011-10-05 2013-04-11 Molmed Spa Viral vectors purification system
US20140037599A1 (en) * 2012-08-03 2014-02-06 The Trustees Of The University Of Pennsylvania Compositions and Methods of Treating T Cell Deficiency

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055459A (en) * 1986-06-30 1991-10-08 Board Of Regents, The University Of Texas Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates
WO1991016069A1 (en) * 1990-04-17 1991-10-31 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Selective cytotoxic reagents comprising toxic moieties derived from mammalian proteins
CA2040099A1 (en) * 1990-05-01 1991-11-02 Mariano Barbacid Tyrosine kinase negative trkb
US5462856A (en) * 1990-07-19 1995-10-31 Bunsen Rush Laboratories, Inc. Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
ES2080341T3 (es) * 1990-09-14 1996-02-01 Univ Johns Hopkins Metodos y composiciones para la terapia genetica y la potenciacion de la inmunidad antitumoral.
US5470730A (en) * 1990-09-28 1995-11-28 Immunex Method for producing TH -independent cytotoxic T lymphocytes
EP0557459B1 (de) * 1990-11-13 1997-10-22 Immunex Corporation Bifunktionelle wählbare fusionsgene
AU9164991A (en) * 1990-11-30 1992-06-25 Abbott Laboratories Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor
AU1922092A (en) * 1991-05-03 1992-12-21 Albert Einstein College Of Medicine Of Yeshiva University Targeted delivery of genes encoding cell surface receptors
US5529774A (en) * 1991-08-13 1996-06-25 The Regents Of The University Of California In vivo transfer of the HSV-TK gene implanted retroviral producer cells
JP2006344159A (ja) * 2005-06-10 2006-12-21 Toshiba Information Systems (Japan) Corp 共通バス接続デバイス用通信制御装置

Also Published As

Publication number Publication date
PT724634E (pt) 2004-03-31
US6074836A (en) 2000-06-13
WO1995006723A1 (en) 1995-03-09
ITRM930587A0 (it) 1993-09-01
DK0724634T3 (da) 2004-03-29
IL110815A0 (en) 1994-11-11
JP2781276B2 (ja) 1998-07-30
CA2170757C (en) 2003-04-22
DE69433342D1 (de) 2003-12-24
IT1261847B (it) 1996-06-03
IL147557A (en) 2006-10-31
DE69433342T2 (de) 2004-09-09
EP0724634B1 (de) 2003-11-19
ITRM930587A1 (it) 1995-03-01
ES2210260T3 (es) 2004-07-01
EP0724634A1 (de) 1996-08-07
JPH09501569A (ja) 1997-02-18
CA2170757A1 (en) 1995-03-09

Similar Documents

Publication Publication Date Title
ATE254660T1 (de) Methode zur markierung von eukaryotischen zellen mittels verwendung von rezeptoren der zelloberfläche als marker
Galko et al. Function of an axonal chemoattractant modulated by metalloprotease activity
Boyd et al. LacZ-expressing olfactory ensheathing cells do not associate with myelinated axons after implantation into the compressed spinal cord
Blüml et al. Identification of an intracellular tyrosine residue critical for muscarinic receptor-mediated stimulation of phosphatidylinositol hydrolysis.
Prochazka et al. Epidermal growth factor-receptor tyrosine kinase activity regulates expansion of porcine oocyte-cumulus cell complexes in vitro
Christen et al. Regeneration‐specific expression pattern of three posterior Hox genes
Field et al. Refining instrument attachment on phocid seals.
TW200607814A (en) Cell surface receptor isoforms and methods of identifying and using the same
DE69808274D1 (de) Kombinationsprodukt, enthaltend eine nukleinsäure und eine substanz, die die extrazellulärematrix desorganisiert, zur verwendung in gentherapie
ATE374642T1 (de) Verwendung von spezifischen erbb4 antagonisten zur behandlung von stenose
ATE430807T1 (de) Verfahren zur kultivierung von circovirus
WO2004065560A3 (en) Methods of screening for modulators of nerve growth factor
NO955011L (no) Intracellulære bindingsproteiner og deres anvendelse
ATE380876T1 (de) Fusionsproteine mit pestizidwirkung
Fassini et al. The reaction of the sponge Chondrosia reniformis to mechanical stimulation is mediated by the outer epithelium and the release of stiffening factor (s)
Balasubramanian et al. Phosphorylation of the regulator of G protein signaling RGS9-1 by protein kinase A is a potential mechanism of light-and Ca2+-mediated regulation of G protein function in photoreceptors
Qi et al. ATP reduces gel compaction in osteoblast-populated collagen gels
Iwao Mechanisms of egg activation and polyspermy block in amphibians and comparative aspects with fertilization in other vertebrates
DE60320302D1 (de) Verfahren zur identifikation von modulatoren des humanen orexin-2-rezeptors
DE60036474D1 (de) Methode zur Identifizierung eines zellulären Rezeptors durch Flotation
DK1064018T3 (da) Anvendelsen af isolerede domæner af Type IV kollagen til at modificere celle- og vævsinteraktioner
AP2368A (en) Novel expression vectors and uses thereof.
ATE191223T1 (de) Verwendung von zelladhäsions-peptiden zur modifikation des haftungsvermögens eukaryontischer zellen untereinander
NO20050641L (no) Drosophilia G-proteinkoplete reseptorer, nukleinsyrer og fremgangsmater som angar disse
Levinson et al. Overexpression of integrin αv promotes human osteosarcoma cell populated collagen lattice contraction and cell migration

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0724634

Country of ref document: EP